Evidence map›Paper›PMID 35472097›Full record

Trial reportThe American journal of clinical nutrition2022

Gastrointestinal dysfunction during enteral nutrition delivery in intensive care unit (ICU) patients: Risk factors, natural history, and clinical implications. A post-hoc analysis of The Augmented versus Routine approach to Giving Energy Trial (TARGET).

Tejaswini Arunachala Murthy, Lee-Anne S Chapple, Kylie Lange, Chinmay S Marathe, Michael Horowitz, Sandra L Peake, Marianne J Chapman

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02306746 phase3completednot on this map

The Augmented Versus Routine Approach to Giving Energy Trial: A Randomised Controlled Trial

TypeinterventionalSponsorAustralian and New Zealand Intensive Care Research CentreRan2016 to 2018Enrolled4,000ConditionsCritical IllnessArmsTARGET protocol EN 1.5 kcal/mL, TARGET protocol EN 1.0 kcal/mL
NCT07640633 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Fecal Microbiota Transplantation for Feeding Intolerance Due to Gastrointestinal Dysfunction in Critically Ill Patients: A Single-Center, Single-Blind, Randomized Controlled Trial

TypeinterventionalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2026 to 2027Enrolled60ConditionsFeeding Intolerance, Gastrointestinal Dysfunction, Critically Ill Intensive Care Unit PatientsArmsFecal microbiota transplantation (FMT)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Elevated Intra-Abdominal Pressure as a Prognostic Marker of Enteral Nutrition Intolerance and Adverse Outcomes in Neurocritical Care: A Retrospective Cohort Study.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tejaswini Arunachala MurthyAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0003-3793-3552
Lee-Anne S ChappleAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-9818-2484
Kylie LangeAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0003-3814-8513
Chinmay S MaratheAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-8086-2449
Michael HorowitzAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0002-0942-0306
Sandra L PeakeAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0001-6682-7973
Marianne J ChapmanAdelaide Medicine School, University of Adelaide, Adelaide, Australia.ORCID 0000-0003-0710-3283

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSlow gastric emptying occurs frequently during critical illness and is roughly quantified at bedside by large gastric residual volumes (GRVs). A previously published trial (The Augmented versus Routine approach to Giving Energy Trial; TARGET) reported larger GRVs with energy-dense (1.5 kcal/mL) compared with standard (1.0 kcal/mL) enteral nutrition (EN), warranting further exploration.

objectiveTo assess the incidence, risk factors, duration, and timing of large GRVs (≥250 mL) and its relation to clinical outcomes in mechanically ventilated adults.

methodsA post-hoc analysis of TARGET data in patients with ≥1 GRV recorded. Data are n (%) or median [IQR].

resultsOf 3876 included patients, 1777 (46%) had ≥1 GRV ≥250 mL, which was more common in males (50 compared with 39%; P < 0.001) and in patients receiving energy-dense compared with standard EN (52 compared with 40%; RR = 1.27 (95% CI: 1.19, 1.36); P < 0.001) in whom it also lasted longer (1 [0-2] compared with 0 [0-1] d; P < 0.001), with no difference in time of onset after EN initiation (day 1 [0-2] compared with 1 [0-2]; P = 0.970). Patients with GRV ≥250 mL were more likely to have the following: vasopressor administration (88 compared with 76%; RR = 1.15 [1.12, 1.19]; P < 0.001), positive blood cultures (16 compared with 8%; RR = 1.92 [1.60, 2.31]; P < 0.001), intravenous antimicrobials (88 compared with 81%; RR = 1.09 [1.06, 1.12]; P < 0.001), and prolonged intensive care unit (ICU) stay (ICU-free days to day 28; 12.9 [0.0-21.0] compared with 20.0 [3.9-24.0]; P < 0.001), hospital stay (hospital-free days to day 28: 0.0 [0.0-12.0] compared with 7.0 [0.0-17.6] d; P < 0.001), ventilatory support (ventilator-free days to day 28: 16.0 [0.0-23.0] compared with 22.0 [8.0-25.0]; P < 0.001), and a higher 90-d mortality (29 compared with 23%; adjusted: RR = 1.17 [1.05, 1.30]; P = 0.003).

conclusionLarge GRVs were more common in males and those receiving energy-dense formulae, occurred early and were short-lived, and were associated with a number of negative clinical sequelae, including increased mortality, even when adjusted for illness severity. This trial was registered at clinicaltrials.gov as NCT02306746.

Indexed as

Enteral NutritionGastrointestinal DiseasesAdultCritical CareCritical IllnessHumansIntensive Care UnitsMaleRisk Factorscritical illnessenteral nutritiongastric emptyinggastric residual volumegastrointestinal dysfunction

Identifiers

PMID35472097
PMCPMC9348974

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.